Washington Examiner
Sign in Subscribe
News
Politics
White House
Senate
House
Campaigns
Business
World
Investigations
Justice
Supreme Court
Crime
Entertainment
Washington Secrets
Policy
Defense
National Security
Energy and Environment
Education
Immigration
Finance and Economy
Healthcare
Foreign Policy
Tech
Infrastructure
Space
2026 Election
America at 250
IN FOCUS
Commentary
Columnists
Editorials
Think Tanks
Beltway Confidential
Op-Eds
Restoring America
Patriotism and Unity
Faith, Freedom, and Self-Reliance
Courage, Strength, and Optimism
Equality, Not Elitism
Community and Family
Fairness and Justice
Mission
Watch
Magazine
Magazine
Quarterly Briefing
Archives
Games
Sponsored
Protecting Air Ambulance Services
Powering Progress
ASAE – Association Leadership
National Parks
Examining Tax Reform
Fix TSCA
Inside the Corn Belt
Examining Transportation
Newsletters
Sign In Sign InHome
News
Politics
Policy2026 Election
Opinion
EditorialsOp-Eds
In FocusRestoring AmericaMagazineWatch
Sponsored
Protecting Air Ambulance ServicesPowering ProgressASAE – Association LeadershipNational ParksExamining Tax ReformFix TSCAInside the Corn BeltExamining Transportation
TWS Archive
Advertisement
Home › Tags › Posts tagged Pharmaceutical Industry

Tag: Pharmaceutical Industry

Glenn Adam Chin, left, a former supervisory pharmacist at the New England Compounding Center, walks with his attorney Paul Shaw, right, after appearing in federal court, Thursday, Sept. 4, 2014, in Boston. The pharmacy, which custom-mixed medications in bulk, has been blamed for a 2012 outbreak of fungal meningitis that killed 64 people. Chin was charged with one count of mail fraud, but federal prosecutors said it is part of a larger criminal investigation of Chin and others. (AP Photo/Steven Senne) Business

Pharmacist arrested in tainted steroid case

Denise Lavoie · September 5, 2014 3:04 am
FILE - In this Thursday, Feb. 28, 2013 file photo, a Merck logo is placed on scientist's lab coat in West Point, Pa. The Food and Drug Administration on Thursday, Sept. 4, 2014 said it has granted accelerated approval to Merck's Keytruda, for treating melanoma that's spread or can't be surgically removed, in patients previously treated with another drug. (AP Photo/Matt Rourke, File) Business

FDA OKs Merck drug, 1st in new cancer drug class

Linda Johnson · September 4, 2014 9:41 pm
Highmark sues UPMC over billing for cancer drugs Business

Highmark sues UPMC over billing for cancer drugs

Washington Examiner · September 4, 2014 7:08 pm
FDA: Little evidence to support testosterone drugs Business

FDA: Little evidence to support testosterone drugs

Matthew Perrone · September 3, 2014 7:18 pm
FILE - In this April 1, 2013 file photo, a dove flies near the logo of Novartis India Limited at their head office in Mumbai, India. A new study released Saturday, Aug. 30, 2014, shows an experimental Novartis drug, which does not have a name, lowered the chances of death or hospitalization by about 20 percent. (AP Photo/Rafiq Maqbool, File) Business

Study: Novel heart failure drug shows big promise

Marilynn Marchione · August 30, 2014 11:10 am
FILE - In this undated file photo provided by Kentucky BioProcessing, tobacco plants are grown in a controlled environment at the Kentucky BioProcessing facility in Owensboro, Ky. The company is using tobacco plants grown at this facility to help manufacture an experimental drug to treat patients infected with Ebola. An experimental Ebola drug healed all 18 monkeys infected with the deadly virus in a study released Friday, Aug. 29, 2014. (AP Photo/Kentucky BioProcessing, File) Business

Experimental Ebola drug heals all monkeys in study

Marilynn Marchione · August 29, 2014 9:03 pm
FDA approves Biogen’s MS drug Plegridy Business

FDA approves Biogen’s MS drug Plegridy

Washington Examiner · August 15, 2014 11:27 pm
Alabama high court upholds generic drug decision Business

Alabama high court upholds generic drug decision

Washington Examiner · August 15, 2014 8:47 pm
FDA clears Avastin for late-stage cervical cancer Business

FDA clears Avastin for late-stage cervical cancer

Washington Examiner · August 15, 2014 5:48 pm
$580 million EU antitrust fine for drug makers Business

$580 million EU antitrust fine for drug makers

Washington Examiner · July 9, 2014 9:59 am
It's no surprise the manufacturers and sellers of sterilization and contraception have lobbied on the Obama administration's contraception mandate, backed the Obamacare law Obama uses to justify the mandate, and fought for Obama's election and re-election. (iStock Photo) Beltway Confidential

The drug lobby vs. Hobby Lobby: Pharma lobbyists and the contraception mandate

Timothy P. Carney · June 30, 2014 8:44 am
(Thinkstock) Columnists

Who should have say on a patient taking experimental drugs?

Walter Williams · June 9, 2014 3:52 pm
Advertisement
  • ‹Previous page
  • 1
  • …
  • 133
  • 134
  • 135
  • 136
  • 137
  • …
  • 142
  • ›Next page
Page 135 of 142
Advertisement
Washington Examiner Manage Preferences

News

  • Politics
    • White House
    • Senate
    • House
    • Campaigns
  • Business
  • World
  • Investigations
  • Justice
  • Supreme Court
  • Crime
  • Washington Secrets
  • Entertainment
  • Sports

Policy

  • Defense
  • National Security
  • Energy
  • Immigration
  • Finance and Economy
  • Healthcare
  • Foreign Policy
  • Tech
  • Infrastructure
  • Space

Commentary

  • Columnists
  • Editorials
  • Think Tanks
  • Beltway Confidential
  • Op-Eds

Restoring America

  • Patriotism & Unity
  • Faith, Freedom & Self-Reliance
  • Courage, Strength & Optimism
  • Equality, Not Elitism
  • Community & Family
  • Fairness & Justice
  • Mission

Watch

  • Shows
NEWSLETTERS MAGAZINE ARCHIVE
  • Policies and Standards
  • Terms Of Service
  • Subscription Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Transparency In Coverage
  • Advertise
  • Subscribe
  • Contact
  • Careers
  • Staff
  • About Examiner
  • Facebook
  • Twitter
© Copyright 2026. Washington Examiner. All Rights Reserved.
Advertisement